posted
Press Release Source: AVANT Immunotherapeutics, Inc.
AVANT to Pursue Development of Avian Flu Vaccine Monday November 14, 8:01 am ET
NEEDHAM, Mass.--(BUSINESS WIRE)--Nov. 14, 2005--AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN - News) today announced that it has formed a research team to focus on development of an avian flu vaccine utilizing in part AVANT's proprietary bacterial vectoring technologies and VitriLife® preservation processes
Posts: 10729 | From: oregon | Registered: Feb 2005
| IP: Logged |